Patents by Inventor Benjamin J. Henley

Benjamin J. Henley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220194902
    Abstract: The present invention relates to a method of preparing Cabozantinib (Cyclopropane-1,1-dicarboxylic acid [4-(6,7-di-methoxy-quinolin-4-vloxy)-phenyl]amide (4-fluoro-phenyl)amide) and 18F labeled Cabozantinib.
    Type: Application
    Filed: September 3, 2021
    Publication date: June 23, 2022
    Inventors: Wei Xu, David J. Donnelly, Patrick L. Chow, Benjamin J. Henley
  • Patent number: 11124481
    Abstract: The present invention relates to a method of preparing Cabozantinib (Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenylo]amide(4-fluoro-phenyl)amide) and 18F labeled Cabozantinib.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: September 21, 2021
    Assignee: Exelixis, Inc.
    Inventors: Wei Xu, David J. Donnelly, Patrick L. Chow, Benjamin J. Henley
  • Publication number: 20170217896
    Abstract: The present invention relates to a method of preparing Cabozantinib (Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenylo]amide(4-fluoro-phenyl)amide) and 18F labeled Cabozantinib.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 3, 2017
    Inventors: Wei XU, David J. Donnelly, Patrick L. Chow, Benjamin J. Henley